RAG, fine-tuning, agents, or rules: choosing by regulated use case
Medical device manufacturers rarely need a single AI pattern for every workflow. A design-control assistant, a submission-authoring tool, and a post-market surveillance application operate on different evidence, failure consequences, and review paths. Architecture should follow intended use and risk rather than whichever model produced the best demonstration.
When evaluating Generative AI in MedTech, four approaches appear repeatedly: prompt-only generation, retrieval-augmented generation, fine-tuned models, and tool-using agents. Deterministic rules remain an important fifth ingredient because not every task should be delegated to a probabilistic model.
Prompt-Only Models
A prompt-only application sends instructions and user-provided context directly to a general model. It is fast to prototype and useful for low-risk drafting, rewriting, taxonomy brainstorming, or converting already approved text into a requested format.
Advantages include minimal infrastructure, quick experimentation, and simple comparison across models. The limitations are substantial: the model lacks reliable access to the current design history file, QMS procedures, product-specific risk controls, or submission commitments. Users may paste sensitive information into an unapproved service, and outputs may contain plausible but unsupported claims.
This approach fits disposable experiments with de-identified content. It is a poor choice for final clinical evaluation conclusions, 510(k) substantial-equivalence claims, PMA evidence summaries, or complaint reportability decisions.
Retrieval-Augmented Generation
Retrieval-augmented generation, or RAG, searches an authorized corpus and supplies relevant records to the model. For Generative AI in MedTech, RAG is often the strongest default for knowledge-intensive workflows because it can ground a response in controlled procedures, approved test reports, risk-management records, and current product documentation.
Its advantages are source visibility, faster knowledge updates, and the possibility of preserving document-level permissions. It can support traceable questions such as which verification reports cover a specific design input or which complaints resemble a reported failure mode.
RAG does not guarantee correctness. Retrieval may return the wrong device family, an obsolete revision, or only part of the necessary evidence. Teams must validate chunking, metadata filters, ranking, citation accuracy, and behavior when sources disagree. A generated citation is not useful unless it resolves to the exact controlled record and revision reviewed.
Fine-Tuned Models
Fine-tuning changes model behavior using curated examples. It can improve consistency for specialized classification, structured extraction, company terminology, or recurring document formats. A supplier-quality team might use it to normalize nonconformance descriptions, while clinical affairs might use it to produce a consistent evidence-extraction structure.
The benefit is repeatable behavior with less prompt content. The tradeoffs include dataset curation, privacy review, bias assessment, version control, and the risk of encoding historical errors. Fine-tuning is also a weak mechanism for memorizing frequently changing facts. Current procedures and design records are usually better supplied through retrieval.
Use fine-tuning when the problem concerns stable behavior or format, not simply access to current knowledge. Maintain training-data provenance and an independent evaluation set so apparent gains are not the result of duplicated examples.
Tool-Using Agents
Agents combine a generative model with tools, memory, workflow logic, and iterative planning. An agent might retrieve user needs, identify linked design inputs, find verification evidence, compare revision states, and create a draft traceability-gap report. Specialized AI agent development expertise can help implement these orchestrations, but the controls around tool access are as important as model quality.
Agents offer the highest automation potential and the largest execution surface. A mistaken answer is one failure mode; an unauthorized record update, excessive data access, or looping tool call is another. Limit permissions, separate read and write tools, cap iterations, require approval gates, and log every retrieval and action.
Autonomous agents should not silently approve CAPAs, close complaints, alter a device master record, or release a regulatory submission. Those actions have established QMS responsibilities and segregation-of-duty expectations.
Deterministic Rules as the Control Layer
Rules are predictable, testable, and appropriate for known constraints. They should handle required-field checks, date calculations, document-state enforcement, approved terminology, and routing based on defined criteria. Their weakness is brittleness when language or context varies.
The most defensible Generative AI in MedTech architecture is often hybrid:
- Rules enforce deadlines, permissions, and mandatory workflow states
- RAG supplies current, authorized evidence
- A fine-tuned or prompted model structures and summarizes content
- An agent coordinates bounded steps where orchestration adds value
- A qualified person reviews consequential conclusions
This composition also makes verification easier because each component has a narrower responsibility and clearer failure modes.
Conclusion
No approach wins every regulated workflow. Prompt-only generation is useful for exploration, RAG supports current evidence, fine-tuning shapes stable behavior, agents coordinate multi-step work, and deterministic rules protect hard constraints. Teams comparing MedTech AI Solutions should select the smallest architecture that satisfies the intended use, then validate the complete configuration under realistic conditions. Generative AI in MedTech earns trust through bounded authority, source traceability, and disciplined lifecycle control—not through model size alone.
Top comments (0)